Literature DB >> 21508386

Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case-control study.

Gabriella Bianchino1, Achille Cittadini, Vitina Grieco, Antonio Traficante, Angela Zupa, Giuseppina Improta, Michele Aieta, Alessandro Sgambato.   

Abstract

BACKGROUND: Polymorphisms in genes encoding enzymes involved in xenobiotic metabolism and/or in cellular defenses against carcinogen-induced DNA damage play an important role in determining individual cancer susceptibility. However, their distribution and association with cancer susceptibility can vary in different populations.
MATERIALS AND METHODS: A case-control study including 290 cancer patients (cases) and 242 controls was performed to evaluate the relationship between polymorphisms of cytochrome P450 (CYP)1A1 and CYP2E1 and X-ray repair complementing defective repair in Chinese hamster cells (XRCC)1 genes and the risk of developing cancer in a Southern Italian (Basilicata) population. Genomic DNA was isolated from 5 ml whole blood and genotyping was performed using a PCR-RFLP technique.
RESULTS: No significant differences were observed in the distribution of the CYP1A1, CYP2E1 and XRCC1 gene polymorphisms between the cases and controls in the population under study.
CONCLUSION: The distribution of CYP1A1, CYP2E1 and XRCC1 gene polymorphisms in the Basilicata population is not different from that of other Italian regions or from that reported in the literature for Caucasian populations, and polymorphisms in these genes do not play an important role in determining cancer risk in the population under study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508386

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

2.  XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Yunpeng Qi; Lianhua Cui; Yang Song; Na Li
Journal:  Mol Biol Rep       Date:  2014-01-04       Impact factor: 2.316

Review 3.  CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.

Authors:  Sumaira Akhtar; Ishrat Mahjabeen; Zertashia Akram; Mahmood Akhtar Kayani
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

4.  The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population.

Authors:  Merve Arici; Gül Özhan
Journal:  Saudi Pharm J       Date:  2016-06-16       Impact factor: 4.330

5.  Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk.

Authors:  Yeqing Mao; Xin Xu; Yiwei Lin; Hong Chen; Jian Wu; Zhenghui Hu; Yi Zhu; Xianglai Xu; Liping Xie
Journal:  World J Surg Oncol       Date:  2013-03-07       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.